Dermal Cell News Volume 10.10 | April 15 2024

    0
    9







    2024-04-15 | DCN 10.10


    Dermal Cell News by STEMCELL Technologies
    Vol. 10.10 – 15 April, 2024
    TOP STORY

    A Viscous-Biofluid Self-Pumping Organohydrogel Dressing to Accelerate Diabetic Wound Healing

    The authors reported that a self-pumping organohydrogel dressing, prepared by a three-dimensional-templated wetting-enabled-transfer polymerization process, could efficiently drain viscous fluids and accelerate diabetic wound healing.
    [Advanced Materials]

    Abstract
    Request a free copy of this wallchart for an overview of the different types of pluripotent cells
    PUBLICATIONSRanked by the impact factor of the journal

    Prevented Cell Clusters’ Migration via Microdot Biomaterials for Inhibiting Scar Adhesion

    Scientists constructed a microdot biomaterial system, which released functionalized polypeptides targeting mitochondria and promoted the influx of extracellular calcium ions under the inflammatory environment, thus inhibiting the expression of N-cadherin mediating cell-cell interaction.
    [Advanced Materials]

    Abstract

    Conductive Hyaluronic Acid/Deep Eutectic Solvent Composite Hydrogel as a Wound Dressing for Promoting Skin Burn Healing under Electrical Stimulation

    The authors introduced a double-network conductive eutectogel, simulating the conductivity and mechanical strength of natural human skin. When combined with exogenous electrical stimulation, the eutectogel exhibited the ability to reduce inflammation and facilitate skin tissue remodeling.
    [Advanced Healthcare Materials]

    Abstract

    Inactivation of Kindlin-3 Increases Human Melanoma Aggressiveness through the Collagen-Activated Tyrosine Kinase Receptor DDR1

    Researchers demonstrated that kindlin-3 inactivation through knockdown or somatic mutations increased BRAFV600mut melanoma cells oncogenic properties via collagen-related signaling by decreasing cell adhesion and enhancing proliferation and migration in vitro, and by promoting tumor growth in mice.
    [Oncogene]

    Abstract

    A Novel Long Non-Coding RNA SLNCR1 Promotes Proliferation, Migration, and Invasion of Melanoma via Transcriptionally Regulating SOX5

    Investigators showed that steroid receptor RNA activator-like non-coding RNA (SLNCR1) was significantly up-regulated in human malignant melanoma tissues and cell lines and functioned as an oncogene.
    [Cell Death Discovery]

    Full ArticleGraphical Abstract

    Orthotopic Model for the Analysis of Melanoma Circulating Tumor Cells

    Scientists established a xenograft model of human melanoma that spontaneously metastasized to lymph nodes and lungs. This model allowed precise monitoring of melanoma progression, and was suitable for the quantitative and qualitative analysis of circulating tumor cells.
    [Scientific Reports]

    Full Article

    The Podoplanin-CLEC-2 Interaction Promotes Platelet-Mediated Melanoma Pulmonary Metastasis

    Researchers investigated the role of the podoplanin-platelet C-type lectin-like receptor 2 (CLEC-2) interaction in melanoma pulmonary metastasis, and reported that the platelet Syk-dependent signaling pathway contributed to platelet aggregation and melanoma metastasis.
    [BMC Cancer]

    Full Article
    See how small molecules affect key signaling pathways in cancer research. Download your free wallchart now.
    REVIEWS

    Melanocytes in Regenerative Medicine Applications and Disease Modeling

    The authors discuss the role of melanocytes in homeostasis and disease, before discussing their potential in regenerative medicine applications, such as for disease modeling, drug testing, or therapy development using stem cell technologies, tissue engineering, and extracellular vesicles.
    [Journal Of Translational Medicine]

    Full Article
    INDUSTRY AND POLICY NEWS

    Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed With Enhanced Host Conditioning

    Achilles Therapeutics announced interim Phase I/IIa data on the use of clonal neoantigen reactive T cells from the CHIRON study in advanced unresectable or metastatic non-small cell lung cancer, and the THETIS study in recurrent or metastatic malignant melanoma.
    [Achilles Therapeutics]

    Press Release
    FEATURED EVENT

    ISCT 2024

    May 29 – June 1, 2024
    Vancouver, British Columbia, Canada

    > See All Events

    JOB OPPORTUNITIES

    Laboratory Research Technician – Pathology

    University of Pittsburgh – Pittsburgh, Pennsylvania, United States

    Research Technician – Biological Sciences

    University of Luxembourg – Esch-sur-Alzette, Luxembourg

    Postdoctoral Researcher – Scleroderma

    Boston University – Boston, Massachusetts, United States

    Postdoctoral Researcher – Translational Melanoma Research

    Karolinska Institute – Solna, Sweden

    Postdoctoral Researcher – Skin Development, Wound Healing, & Cancer

    University of Texas Southwestern Medical Center – Dallas, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2